The Journal of Practical Medicine >
Up⁃regulated miR⁃106b⁃5p in exosomes derived from pulmonary artery smooth muscle cells enhances Warburg effect of pulmonary artery endothelial cells and promotes arterial pulmonary hypertension
Received date: 2023-04-21
Online published: 2023-09-27
Objective To explore the mechanisms of inter-cellular communication between pulmonary artery smooth muscle cells and pulmonary artery endothelial cells in promoting the progression of arterial pulmonary hypertension (PAH). Methods Exosomes in peripheral blood of healthy individuals (HC) and PAH patients were collected and isolated, and miRNAs in the exosomes were determined by microarray and differential expression analysis. Primary human pulmonary artery smooth muscle cells (hPASMCs) and primary human pulmonary artery endothelial cells (hPAECs) were treated with normoxia or hypoxia in vitro. Bioinformatics analysis was performed to detect sequence interaction sites between miR-106b-5p and USP32. Adenovirus was transinfectedinto the hPASMCs of over-expressed/knocked-down miR-106b-5p, or into the hPAECs of the over-expressed/knocked-down of PKM2. Dual luciferase reporter assay was used for confirming the sequence interaction of miR-106b-5p and USP32. The levels of USP32, PKM2, GLUT1, HK2 and LDHA were determined by Western blot. Results By microarray assay and differential expression analysis, the level of miR-106b-5p in the peripheral blood-derived exosomes was significantly up-regulated in the PAH group as compared with HC group. Compared with normoxia group cells, the level of miR-106b-5p was significantly up-regulated in the hypoxia-induced hPASMCs cells’ supernatant exomsomes, but not in the exosomes of hPAECs cells’ supernatant. MiR-106b-5p negatively regulated the expression of USP32. Compared with the miR-NC group/inhibitor-NC group,the expressions of PKM2, GLUT1, HK2 and LDHA were significantly enhanced/inhibited after miR-106b-5p mimic/miR-106b-5p inhibitor was treated with hPASMCs. Compared with shRNA-NT/vector group, PKM2 shRNA/PKM2-OE treatment in hPAECs significantly inhibited/enhanced intracellular expressions of PKM2, GLUT1, HK2, and LDHA (P<0.05). Conclusion HPASMCs enhances intracellular Warburg effect of hPAECs through up-regulating miR-106b-5p in exosomes, which has a potential role in promoting disease progression in arterial pulmonary hypertension.
Ailifeire MAIMAITI , Jing GAO , Zixiang YU , Yitong. MA . Up⁃regulated miR⁃106b⁃5p in exosomes derived from pulmonary artery smooth muscle cells enhances Warburg effect of pulmonary artery endothelial cells and promotes arterial pulmonary hypertension[J]. The Journal of Practical Medicine, 2023 , 39(17) : 2190 -2195 . DOI: 10.3969/j.issn.1006-5725.2023.17.007
| 1 | THENAPPAN T, ORMISTON M L, RYAN J J, et al. Pulmonary arterial hypertension: pathogenesis and clinical management [J]. BMJ, 2018, 360:j5492. |
| 2 | 朱玉菡,江其敏,沈晓旭,等. ICU肺动脉高压患者右心功能的超声研究[J]. 实用医学杂志,2017,33(2):246-249. |
| 3 | ANDERSON J J, LAU E M. Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia [J]. JACC Asia, 2022, 2(5):538-546. |
| 4 | RUOPP N F, COCKRILL B A. Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review [J]. JAMA, 2022, 327(14):1379-1391. |
| 5 | 罗勤,柳志红,奚群英,等. 中国动脉型肺动脉高压患者生存现状调查[J]. 中国循环杂志, 2022, 37(11):1111-1115. |
| 6 | SOMMER N, GHOFRANI H A, PAK O, et al. Current and future treatments of pulmonary arterial hypertension [J]. Br J Pharmacol, 2021, 178(1):6-30. |
| 7 | 董昕,刘越,张晓卉,等. 血管重构在动脉型肺动脉高压中的研究进展[J]. 心脏杂志, 2017, 29(3):361-364. |
| 8 | RHODES C J. The cancer hypothesis of pulmonary arterial hypertension: are polyamines the new Warburg?[J]. Eur Respir J, 2020, 56(5):2002350. |
| 9 | GAAL Z. MicroRNAs and Metabolism: Revisiting the Warburg Effect with Emphasis on Epigenetic Background and Clinical Applications[J]. Biomolecules, 2021, 11(10):1531. |
| 10 | HOGAN S E, RODRIGUES SALAZAR M P, CHEADLE J, et al. Mesenchymal stromal cell-derived exosomes improve mitochondrial health in pulmonary arterial hypertension [J]. Am J Physiol Lung Cell Mol Physiol, 2019, 316(5):L723-L737. |
| 11 | YANG L, XIE M, YANG M, et al. PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis [J]. Nat Commun, 2017, 5:4436. |
| 12 | COONS J C, POGUE K, KOLODZIEJ A R, et al. Pulmonary Arterial Hypertension: a Pharmacotherapeutic Update [J]. Curr Cardiol Rep, 2019, 21(11):141. |
| 13 | LUO X, HANG C, ZHANG Z, et al. PVECs-Derived Exosomal microRNAs Regulate PASMCs via FoxM1 Signaling in IUGR-induced Pulmonary Hypertension [J]. J Am Heart Assoc, 2022, 11(24):e027177. |
| 14 | WANG Z, LI T E, CHEN M, et al. miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway [J]. Aging (Albany NY), 2020, 12(2):1867-1887. |
| 15 | FARRE P L, DUCA R B, MASSILLO C, et al. MiR-106b-5p: A Master Regulator of Potential Biomarkers for Breast Cancer Aggressiveness and Prognosis [J]. Int J Mol Sci, 2021, 22(20):11135. |
| 16 | CHANDRASEKARAN A P, KAUSHAL K, PARK C H, et al. USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2 [J]. Theranostics, 2021, 11(20):9752-9771. |
| 17 | 沈畅,艾可龙,胡长平. 低氧诱导因子1信号通路调控低氧性肺动脉高压研究进展[J].中国临床药理学与治疗学, 2023, 28(1):114-120. |
| 18 | 杜鹏,张向立,朱勇锋. 血清肌钙蛋白I、内皮素-1联合缺氧诱导因子-1缺对心力衰竭预测价值[J]. 实用医学杂志, 2022, 38(24):3077-3080. |
| 19 | DENG H, TIAN X, SUN H, et al. Calpain-1 mediates vascular remodelling and fibrosis via HIF-1α in hypoxia-induced pulmonary hypertension [J]. J Cell Mol Med, 2022, 26(10):2819-2830. |
/
| 〈 |
|
〉 |